Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.
Amatatsu M, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kijima Y, Kurahara H, Kita Y, Mori S, Sasaki K, Omoto I, Maemura K, Ishigami S, Natsugoe S.
Amatatsu M, et al. Among authors: maemura k.
Cancer Sci. 2018 Mar;109(3):814-820. doi: 10.1111/cas.13508. Epub 2018 Feb 19.
Cancer Sci. 2018.
PMID: 29345842
Free PMC article.